Display options
Share it on

World J Diabetes. 2017 Feb 15;8(2):80-88. doi: 10.4239/wjd.v8.i2.80.

Fuzzy expert system for diagnosing diabetic neuropathy.

World journal of diabetes

Meysam Rahmani Katigari, Haleh Ayatollahi, Mojtaba Malek, Mehran Kamkar Haghighi

Affiliations

  1. Meysam Rahmani Katigari, Haleh Ayatollahi, Mehran Kamkar Haghighi, Department of Health Information Management, School of Health Management and Information Sciences, IRAN University of Medical Sciences, Tehran 1996713883, Iran.

PMID: 28265346 PMCID: PMC5320751 DOI: 10.4239/wjd.v8.i2.80

Abstract

AIM: To design a fuzzy expert system to help detect and diagnose the severity of diabetic neuropathy.

METHODS: The research was completed in 2014 and consisted of two main phases. In the first phase, the diagnostic parameters were determined based on the literature review and by investigating specialists' perspectives (

RESULTS: The final diagnostic parameters included the duration of diabetes, the score of a symptom examination based on the Michigan questionnaire, the score of a sign examination based on the Michigan questionnaire, the glycolysis haemoglobin level, fasting blood sugar, blood creatinine, and albuminuria. The output variable was the severity of diabetic neuropathy which was shown as a number between zero and 10, had been divided into four categories: absence of the disease, (the degree of severity) mild, moderate, and severe. The interface of the system was designed by ASP.Net (Active Server Pages Network Enabled Technology) and the system function was tested in terms of sensitivity (true positive rate) (89%), specificity (true negative rate) (98%), and accuracy (a proportion of true results, both positive and negative) (93%).

CONCLUSION: The system designed in this study can help specialists and general practitioners to diagnose the disease more quickly to improve the quality of care for patients.

Keywords: Artificial intelligence; Diabetes complications; Diabetes mellitus; Diabetic neuropathies; Expert systems; Fuzzy logic

Conflict of interest statement

Conflict-of-interest statement: There are no conflicts of interest arising from this work.

References

  1. Gen Hosp Psychiatry. 2005 Sep-Oct;27(5):344-51 - PubMed
  2. Diabetes Metab Res Rev. 2010 Sep;26(6):481-9 - PubMed
  3. J Diabetes Metab Disord. 2015 Jun 03;14:49 - PubMed
  4. BMJ. 2009 Dec 02;339:b4905 - PubMed
  5. Nat Clin Pract Neurol. 2007 Jun;3(6):331-40 - PubMed
  6. Diabetes Care. 2005 Apr;28(4):956-62 - PubMed
  7. Diabetes Care. 2004 Apr;27(4):955-62 - PubMed
  8. J Diabetes Investig. 2010 Oct 19;1(5):212-28 - PubMed
  9. BMC Med Res Methodol. 2013 Feb 15;13:22 - PubMed
  10. Diabet Med. 2003 May;20(5):368-74 - PubMed
  11. J Mol Graph Model. 2008 Apr;26(7):1131-44 - PubMed
  12. Pain Med. 2009 Mar;10(2):393-400 - PubMed
  13. J Med Syst. 2012 Aug;36(4):2071-83 - PubMed
  14. Diabetes Care. 2003 Jun;26(6):1790-5 - PubMed
  15. Diabetologia. 2000 Aug;43(8):957-73 - PubMed
  16. Clinics (Sao Paulo). 2012;67(2):151-6 - PubMed

Publication Types